During a common cold infection, a molecular machine composed of RNA and protein commandeers host cells to produce millions of viral copies. These components operate in a highly coordinated manner. Previously, scientists could observe the individual molecular components but not their collective interactions. A recent study published in Nature Communications has visualized these interactions at near-atomic resolution, potentially informing new strategies to combat prevalent viral infections.
Enteroviruses: Key Pathogenic Agents
Enteroviruses are a large family of RNA viruses responsible for an enormous range of human illnesses. The group includes the rhinoviruses that cause the common cold, poliovirus (responsible for poliomyelitis), enterovirus D68 (linked to acute flaccid paralysis in children), enterovirus 71 (associated with hand, foot, and mouth disease), and coxsackievirus B3, which can cause a dangerous inflammation of the heart muscle called myocarditis.
Enteroviruses employ a distinctive genomic strategy. Their single-stranded RNA serves dual functions: initially as a template for viral protein synthesis, and subsequently as a template for genome replication. Coordination of this functional switch depends on a regulatory structure at the 5′ end of the viral RNA, known as the cloverleaf RNA (CL).
The Cloverleaf: A Molecular Switch at the Heart of Infection
The cloverleaf RNA derives its name from its structure, which consists of four stem-loop regions (sA, sB, sC, and sD) arranged in a four-leaf clover configuration. Located at the 5′ end of the viral genome, this structure functions as a regulatory hub during infection.
Upon entry into the host cell, the cloverleaf RNA facilitates the recruitment of host ribosomes to initiate translation of viral proteins. After sufficient accumulation of these proteins, the cloverleaf structure mediates a transition from translation to genome replication. This is achieved by assembling a protein complex that circularizes the viral genome and initiates RNA synthesis.
A key factor in this regulatory switch is the viral protein 3CD, which comprises two functional domains: the 3C protease and the 3D RNA-dependent RNA polymerase. The 3C domain specifically binds to the sD stem-loop of the cloverleaf RNA to initiate replication. However, the precise molecular interactions underlying this binding remained unclear until recently.
The Breakthrough: Seeing the Interaction Atom by Atom
Researchers at the University of Maryland, Baltimore County, employed X-ray crystallography to determine the three-dimensional structure of the cloverleaf RNA in complex with the 3C protein. They solved two crystal structures: one depicting the intact cloverleaf bound to 3C at 2.69 Å resolution, and another showing the sD stem-loop bound to 3C at 2.41 Å resolution. These structures provide atomic-level detail as one ångström (equivalent to one ten-billionth of a meter.
The structures answered several long-standing questions at once.
The sD stem-loop alone is sufficient to recruit the 3C protein, while the other three stem-loops do not directly participate in 3C binding. This finding clarifies that sD is the primary target for 3C interaction.
Two distinct 3C protein molecules simultaneously bind to a single sD stem-loop: one near the apical loop and one near the base adjacent to the dinucleotide bulge. Each protein interacts with the lateral surface of the RNA helix. This stoichiometry likely plays a functional role in the initiation of viral genome replication.
The 3C protein primarily interacts with the RNA backbone, rather than with specific nucleotide bases. This indicates that the protein recognizes the three-dimensional shape of the RNA. A region known as the Py•Py helix, characterized by pyrimidine-pyrimidine mismatches, forms a narrower groove that is specifically recognized by 3C. Substituting this region with standard base pairs reduces binding affinity approximately fivefold.
The Molecular Handshake: Key Contacts Revealed
The study mapped specific residues, the amino acid “building blocks” of the 3C protein, that are critical for binding. Two stood out dramatically:
- Arginine-13 (R13): When this single amino acid was mutated to alanine, 3C lost all detectable binding to the cloverleaf RNA. R13 sits in a critical position that reads the major groove of the sD stem near the Py•Py helix. This finding neatly explains earlier observations that mutations at this position in poliovirus completely abolished negative-strand RNA synthesis.
- Lysine-156 (K156): Mutating this residue reduced binding affinity by roughly 50-fold, but didn’t eliminate it entirely. K156 contacts the dinucleotide bulge at the base of the sD stem through a network of hydrogen bonds.
These findings provide a detailed map of the protein-RNA interface, exactly the kind of information needed to design molecules that could block it.
Why 3CD Binds Tighter Than 3C Alone
The 3CD fusion protein, in the form actually deployed during viral replication, binds the cloverleaf with roughly twice the affinity of the isolated 3C protease domain. For years, this difference puzzled scientists. Some proposed that the 3D polymerase domain must also contact the RNA; others speculated that 3D changes 3C’s shape to improve binding.
Using a technique called biolayer interferometry (BLI), the team showed that the 3D domain alone has no detectable affinity for the cloverleaf RNA. Instead, the answer lies in a short, flexible linker just seven amino acids connecting 3C and 3D. Computational modeling using AlphaFold3 suggested that this linker region sits near the cloverleaf RNA when 3CD is bound. When two amino acids in the linker (glutamate-190 and lysine-193) were mutated, the binding affinity of 3CD decreased by 3-fold, providing strong evidence that the linker makes meaningful contacts. In other words, the extra binding strength of 3CD comes not from 3D, but from this small connecting segment.
Potential for Broad-Spectrum Antiviral Development
Perhaps the most exciting implication of this work is the possibility of developing antiviral drugs that target multiple enteroviruses simultaneously. The study tested 3C proteins from three different enteroviruses (CVB3, rhinovirus B14, and enterovirus 71) against cloverleaf RNAs from seven different enteroviral species. The results showed extensive cross-reactivity: the proteins bound CLs from different viral species, often with similar affinity.
This conservation makes sense: the sD stem-loop structure and the 3C RNA-binding surface are remarkably similar across enteroviruses, even when their sequences differ. The virus apparently cannot easily mutate this interaction without breaking its own replication machinery, which is exactly the kind of vulnerability drug developers look for.
The cloverleaf-3CD interaction platform represents a conserved antiviral target. A small molecule that disrupts the sD stem-loop or inhibits the 3C-binding surface could neutralize a broad range of enteroviruses, including those responsible for the common cold, polio, and myocarditis.
What Comes Next
The researchers are clear that this is a structural foundation, not a finished drug. The ternary complex involving cloverleaf RNA, 3CD, and the host protein PCBP2, the full replication initiation complex, has yet to be structurally characterized. Understanding how 3CD binding influences PCBP2 (which binds the other side of the cloverleaf scaffold) will be critical for a complete mechanistic picture.
The availability of a high-resolution atomic map of the cloverleaf-3C interface, with key residues identified and validated, significantly advances rational drug design efforts. Researchers can now screen compound libraries for molecules that target the binding pocket, evaluate their efficacy against multiple enteroviruses, and optimize candidates using the structural information.
The elucidation of the viral structure at atomic resolution provides critical insights that can now be leveraged for antiviral development.
Reference
Das, N. K., Patel, A., Abdelghani, R., & Koirala, D. (2025). Structural basis for 3C and 3CD recruitment by enteroviral genomes during negative-strand RNA synthesis. Nature Communications, 16, 9293. https://doi.org/10.1038/s41467-025-64376-0